HTG Molecular Diagnostics, Inc Earning Date (HTGM)

USA |NASDAQ |USD

HTGM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2022 Sep 2022 - - $-0.60
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2022 Sep 2022 - - $2.52M

Htg Molecular Diagnostics, Inc's next earnings date is Tuesday, Nov 8, 2022 for the fiscal quarter ending Sep 2022.

HTGM Earnings Date & History Chart

HTGM Earnings & Revenue Forecast

HTGM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $-2.00 $-2.54 $-1.68

HTGM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-2.00 $-2.31 $-2.33

HTGM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $17.21M $13.50M $22.00M

HTGM Earnings Date & Revenue History

HTGM Earnings History

|
Show More
Show More

HTGM Revenue History

|
Show More
Show More

Htg Molecular Diagnostics, Inc Next Earnings Date & Report

HTGM Next Earnings Date & Report Preview: Sep 2022 (FQ)

HTGM's next earnings date is Tuesday, Nov 8, 2022 for the fiscal quarter ending Sep 30, 2022.

Htg Molecular Diagnostics, Inc Previous Earnings Dates & Reports

HTGM Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Htg Molecular Diagnostics, Inc's previous earnings date was Aug 10, 2022 for its fiscal quarter ended Jun 30, 2022.

HTGM Previous Earnings Date & Report Recap: Dec 2021 (FY)

Htg Molecular Diagnostics, Inc's previous annual earnings date was Mar 29, 2022 for its fiscal year ended Dec 31, 2021.

HTGM's earnings per share (EPS) was $-2.74, missing the consensus analysts forecast of $-2.54 by 7.90% , and higher than the previous year's EPS (Dec 2020) by -36.90%.

Revenues were $8.91M, worse than the forecast of $8.99M by -0.93%, and up by 4.19% from previous year's revenue.

The company reported a net income of $-17.15M.

Htg Molecular Diagnostics, Inc reported a free cash flow of $-17.15M for its fiscal year, compared to $-16.75M a year ago.

The company ended the fiscal year with $16.88M in total debt, an increase of 37.48% compared to the previous year.